Professor Jason Holford

Appetite-suppressing drugs with brand names such as Azempic, Wegovi and Monjaro have become popular in recent years because they help people to lose weight.

But some can be put off from taking them because they're not very convenient, having to be administered by injections and they have to be stored below a certain temperature.

Professor Giles Yeo, an obesity expert, says taking a daily tablet would make the drugs more accessible, but at the moment there are drawbacks.

Professor Jason Holford is a clinical psychologist who specialises in obesity.

He says taking a daily pill could revolutionise treatment.

The decision by the Food and Drug Administration is a major boost for the Danish manufacturer Novo Nordisk, which hopes to begin selling the medication in the US next month.

Other pharmaceutical companies are developing their own versions.